{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:48:33Z","timestamp":1764251313666},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wales Gene Park"},{"DOI":"10.13039\/501100000311","name":"Tuberous Sclerosis Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000311","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ejca.2012.10.027","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T03:13:05Z","timestamp":1354936385000},"page":"1479-1490","source":"Crossref","is-referenced-by-count":19,"title":["Renal tumours in a Tsc1+\/\u2013 mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin"],"prefix":"10.1016","volume":"49","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kalogerou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gallacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian R.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2012.10.027_b0005","series-title":"The tuberous sclerosis complex","author":"Gomez","year":"1999"},{"key":"10.1016\/j.ejca.2012.10.027_b0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2012.10.027_b0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejca.2012.10.027_b0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ejca.2012.10.027_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.ejca.2012.10.027_b0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.10.027_b0035","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2012.10.027_b0040","first-page":"577","article-title":"Everolimus and giant-cell astrocytomas in tuberous sclerosis","volume":"364","author":"Jia","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.10.027_b0045","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.10.027_b0050","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2012.10.027_b0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.10.027_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejca.2012.10.027_b0065","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1476-5381.2011.01394.x","article-title":"Importance of the multidrug and toxin extrusion MATE\/SLC47A family to pharmacokinetics, pharmacodynamics\/toxicodynamics and pharmacogenomics","volume":"164","author":"Yonezawa","year":"2011","journal-title":"Br J Pharmacol Ther"},{"key":"10.1016\/j.ejca.2012.10.027_b0070","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2012.10.027_b0075","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.10.027_b0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1749-6632.2010.05679.x","article-title":"Metformin in polycystic ovary syndrome","volume":"1205","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejca.2012.10.027_b0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1742-1241.2009.02327.x","article-title":"Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease","volume":"64","author":"Kaser","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejca.2012.10.027_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/biof.127","article-title":"Life span extension by resveratrol, rapamycin, and metformin: the promise of dietary restriction mimetics for an healthy aging","volume":"36","author":"Mouchiroud","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.ejca.2012.10.027_b0095","doi-asserted-by":"crossref","first-page":"E1023","DOI":"10.1152\/ajpendo.00532.2003","article-title":"Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion","volume":"286","author":"Leclerc","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejca.2012.10.027_b0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejca.2012.10.027_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-010-0763-9","article-title":"Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells","volume":"123","author":"Zakikhani","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2012.10.027_b0110","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Ben Sahra","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.10.027_b0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejca.2012.10.027_b0120","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","article-title":"A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma","volume":"14","author":"Wilson","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2012.10.027_b0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2013) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2012.10.027_b0130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.ejrad.2011.06.054","article-title":"T2 weighted MRI for assessing renal lesions in transgenic mouse models of tuberous sclerosis","volume":"81","author":"Kalogerou","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejca.2012.10.027_b0135","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer?","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.027_b0140","doi-asserted-by":"crossref","first-page":"e31900","DOI":"10.1371\/journal.pone.0031900","article-title":"Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)","volume":"7","author":"Auricchio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2012.10.027_b0145","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.10.027_b0150","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.01.035","article-title":"Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin","volume":"202","author":"Hemauer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2012.10.027_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng.735","article-title":"Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes","volume":"43","author":"GoDarts","year":"2011","journal-title":"Nat Genet"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912008611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912008611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:21:30Z","timestamp":1540030890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912008611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0959804912008611"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.10.027","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}